Amylases, nucleic acids encoding them and methods for making and using them
US-9249400-B2 · Feb 2, 2016 · US
US9447397B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447397-B2 |
| Application number | US-44325507-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2007 |
| Priority date | Oct 10, 2006 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to variants of a parent glucoamylase having altered properties (e.g., improved thermostability and/or specific activity). In particular, the present invention provides compositions comprising the variant glucoamylases, including starch hydrolyzing compositions, animal feed compositions and cleaning compositions. The invention also relates to DNA constructs encoding the variants and methods of producing the glucoamylase variants in host cells.
Opening claim text (preview).
What is claimed is: 1. An isolated glucoamylase variant comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 2, wherein said variant includes at least a substitution selected from I43R/F/D/Y/S compared to the amino acid sequence of SEQ ID NO: 2. 2. The isolated glucoamylase variant of claim 1 , wherein said variant includes at least the substitution I43R compared to the amino acid sequence of SEQ ID NO: 2. 3. The isolated glucoamylase variant of claim 1 , which comprises the amino acid sequence that is the I43R substitution variant of the amino acid sequence of SEQ ID NO: 2. 4. The isolated glucoamylase variant of claim 1 , wherein the variant further comprises a substitution in a position selected from: D4L/E/R/S/C/A/Q/W, F5C/M/N/R/S/T/V/W, I12L/R, D24E/L/Y/T, F29L/I/D/C/S/V/W, D44E/H/K/S/N/Y/F/R, Y47W, Y49N, Q70R/K/M/P/G/L/F, Q75R/K/A, R76L/M/K/T/P, P94L, D100W/I/Q/M/P/A/N, N119P/T/Y/D/E, N146S/G/C/H/E/D/T/W/L/M, Q148V/Y/H/A/C/D/G/M/R/S/T, Y169D/F, Q172C/A/D/R/E/F/H/V/L/M/N/S/T/V, E180A/C/G/H/I/L/N/P/Q/R/S/T/V/Y, V181E/C/D/G/H/I/P/T/Y/S/K/F/A, Q208L/A/C/E/N/F/H/T, S211C/R/E/A/Y/W/M/H/L/I/R/Q/T, E243S/R/N/M/Y/A/L, R245A/E/M/I/P/V, I292D/H/P/R/T/N/V/F/L, G294D/E/T/Q/I/A, K297F/L/P/T/M/D/N/Q/A/Y/H/S/R/W, R309A/C/G/H/I/N/P/Q/S/T/W/Y/L, Y310E/G/L/P/S/W/R/Q, D313Q, V314A/R/N/D/C/E/Q/G/H/I/K/L/M/F/P/S/T/W/Y, Y315F, Y316Q/R, N317T/H, K340D/T, K341F/D/P/V/G/S, T350S/E/A/N, Q356H/D/E, T363L/R/C/H/W, S368W/D/F/L, S369F, N376Q/T/H/S/V, Y395Q/R/S, A398S/I/T, S401C/V, R408S, N409W/T/K, T412A/h/K/G, R433H/Q, I436A/T and S451M/T/H compared to the amino acid sequence of SEQ ID NO: 2. 5. The isolated glucoamylase variant of claim 1 , wherein said variant exhibits increased thermostability as compared to the glucoamylase of SEQ ID NO: 2. 6. The isolated glucoamylase variant of claim 1 , wherein said variant exhibits increased specific activity compared to the glucoamylase of SEQ ID NO: 2.
Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title
Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title
Recombinant DNA-technology · CPC title
Cross-Sectional Technologies · mapped topic
Biofuels, e.g. bio-diesel · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.